Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry

Tham T Le,1 David B Price,2– 4 Clement Erhard,5 Bill Cook,6 Anna Quinton,7 Rohit Katial,8 George C Christoff,9 Luis Perez-de-Llano,10 Alan Altraja,11,12 Celine Bergeron,13 Arnaud Bourdin,14 Mariko Siyue Koh,15,16 Lauri Lehtimäki,17,18 Bassam Mahboub,19 Nikolaos G Papadopoulos,20,21 Paul Pfeffer,22,2...

Descripción completa

Detalles Bibliográficos

Autores principales:	Le TT, Price DB, Erhard C, Cook B, Quinton A, Katial R, Christoff GC, Perez-de-Llano L, Altraja A, Bergeron C, Bourdin A, Koh MS, Lehtimäki L, Mahboub B, Papadopoulos NG, Pfeffer P, Rhee CK, Carter V, Martin N, Tran TN
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2024-10-01
Colección:	Journal of Asthma and Allergy
Materias:	biologic disease burden healthcare resource utilization severe asthma
Acceso en línea:	https://www.dovepress.com/disease-burden-and-access-to-biologic-therapy-in-patients-with-severe--peer-reviewed-fulltext-article-JAA
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!